October 6, 2023

Executive Leadership Series: How a CEO Left Semi-Retirement to Lead a Biotech Research Company’s Transition to Product Development

Robert Bitterman Executive Chair and CEO Phio Pharmaceuticals Corp. When Ashton Tweed last talked with Robert Bitterman in 2018, he was helming the dermatology company he […]